FOXO3B
gene geneOn this page
Summary
FOXO3B (forkhead box O3B, HGNC:3822) is a protein-coding gene on chromosome 17p11.2, encoding Forkhead box protein O3B (A0A2Z4LIS9). Transcription factor. It is a selective cancer dependency (DepMap: 15.3% of cell lines).
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in mitochondrial matrix. Predicted to be active in nucleus.
Source: NCBI Gene 2310 — RefSeq curated summary.
At a glance
- Cancer dependency (DepMap): dependent in 15.3% of screened cell lines
- MANE Select transcript:
NM_001368135
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:3822 |
| Approved symbol | FOXO3B |
| Name | forkhead box O3B |
| Location | 17p11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000240445 |
| Ensembl biotype | protein_coding |
| OMIM | 620471 |
| Entrez | 2310 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 retained_intron
ENST00000395675, ENST00000442380, ENST00000443457, ENST00000454745
RefSeq mRNA: 2 — MANE Select: NM_001368135
NM_001368134, NM_001368135
CCDS: CCDS92269
Canonical transcript exons
ENST00000395675 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001522453 | 18667629 | 18673055 |
| ENSE00002718958 | 18681615 | 18681846 |
| ENSE00003877371 | 18682204 | 18682314 |
| ENSE00003878725 | 18680741 | 18680829 |
Expression profiles
Bgee: expression breadth ubiquitous, 133 present calls, max score 84.73.
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ganglionic eminence | UBERON:0004023 | 84.73 | gold quality |
| cortical plate | UBERON:0005343 | 82.48 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.89 | gold quality |
| ventricular zone | UBERON:0003053 | 79.82 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 79.43 | gold quality |
| stromal cell of endometrium | CL:0002255 | 74.65 | gold quality |
| endometrium | UBERON:0001295 | 68.75 | gold quality |
| ovary | UBERON:0000992 | 68.67 | gold quality |
| left ovary | UBERON:0002119 | 68.26 | gold quality |
| islet of Langerhans | UBERON:0000006 | 68.03 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 67.55 | gold quality |
| tonsil | UBERON:0002372 | 66.79 | gold quality |
| placenta | UBERON:0001987 | 66.24 | gold quality |
| lymph node | UBERON:0000029 | 66.21 | gold quality |
| right ovary | UBERON:0002118 | 65.99 | gold quality |
| urinary bladder | UBERON:0001255 | 65.47 | gold quality |
| adrenal tissue | UBERON:0018303 | 65.32 | gold quality |
| corpus callosum | UBERON:0002336 | 64.63 | gold quality |
| vermiform appendix | UBERON:0001154 | 64.48 | gold quality |
| body of uterus | UBERON:0009853 | 64.44 | gold quality |
| uterine cervix | UBERON:0000002 | 64.36 | gold quality |
| gall bladder | UBERON:0002110 | 63.84 | gold quality |
| muscle tissue | UBERON:0002385 | 63.80 | gold quality |
| right coronary artery | UBERON:0001625 | 63.58 | gold quality |
| endocervix | UBERON:0000458 | 63.46 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 63.44 | gold quality |
| myometrium | UBERON:0001296 | 63.36 | gold quality |
| fallopian tube | UBERON:0003889 | 62.72 | gold quality |
| left uterine tube | UBERON:0001303 | 62.48 | gold quality |
| prefrontal cortex | UBERON:0000451 | 62.36 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 8.52 |
Regulation
Is transcription factor: no
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 15.3% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 2)
- our results clearly show that, for reliable genetic investigation of FOXO3A exonic regions, a special study design is mandatory accounting for the FOXO3B sequence homology (PMID:22588664)
- human FOXO3B locus encodes a bona fide human gene; unlike FOXO3A, FOXO3B is cytosolically localized in both the presence and absence of active Akt (PMID:29925039)
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Forkhead box protein O3B — A0A2Z4LIS9 (reviewed: A0A2Z4LIS9)
All UniProt accessions (3): A0A2Z4LIS9, A0A590UJX0, I3L3U3
UniProt curated annotations — full annotation on UniProt →
Function. Transcription factor.
Subcellular location. Cytoplasm. Cytosol.
RefSeq proteins (2): NP_001355063, NP_001355064* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001766 | Fork_head_dom | Domain |
| IPR036388 | WH-like_DNA-bd_sf | Homologous_superfamily |
| IPR036390 | WH_DNA-bd_sf | Homologous_superfamily |
Pfam: PF00250
UniProt features (8 total): compositionally biased region 3, region of interest 2, chain 1, DNA-binding region 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A2Z4LIS9-F1 | 60.11 | 0.15 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 117
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 12 (showing top):
GOBP_RESPONSE_TO_STARVATION, GOCC_MITOCHONDRIAL_MATRIX, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_DN, CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP, GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY, GOMF_CIS_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_RESPONSE_TO_NUTRIENT_LEVELS, GOMF_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING, GOCC_MITOCHONDRION, chr17p11
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700), sequence-specific DNA binding (GO:0043565)
GO Cellular Component (4): nucleus (GO:0005634), cytosol (GO:0005829), cytoplasm (GO:0005737), mitochondrial matrix (GO:0005759)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| cellular anatomical structure | 2 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| nucleic acid binding | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| DNA binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| cytoplasm | 1 |
| intracellular anatomical structure | 1 |
| mitochondrion | 1 |
| intracellular organelle lumen | 1 |
Protein interactions and networks
STRING
610 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FOXO3B | TBC1D28 | Q2M2D7 | 380 |
| FOXO3B | ETV6 | P41212 | 362 |
| FOXO3B | HIF1A | Q16665 | 361 |
| FOXO3B | ETV3 | P41162 | 353 |
| FOXO3B | NTM | Q9P121 | 350 |
| FOXO3B | BHLHE41 | Q9C0J9 | 348 |
| FOXO3B | CDK2 | P24941 | 345 |
| FOXO3B | E2F1 | Q01094 | 343 |
| FOXO3B | CTNNB1 | P35222 | 334 |
| FOXO3B | PTK2 | Q05397 | 323 |
| FOXO3B | TVP23B | Q9NYZ1 | 322 |
| FOXO3B | TP53 | P04637 | 316 |
| FOXO3B | ARL5C | A6NH57 | 314 |
| FOXO3B | SESN3 | P58005 | 307 |
| FOXO3B | POU5F1B | Q06416 | 306 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A0U1RRK4, A0A1W2PPE3, A0A1W2PR82, A0A2Z4LIS9, A2VE02, A4D1S0, A5PKC7, A5PL33, A6H7B4, A6NEL2, A6QP24, A6QPM6, A8MTW9, A8MYA2, D3ZAQ5, D4AAA5, E7EW31, O75474, O75638, O89113, O94850, P0C7X2, P14652, P50617, P70339, Q2KIS6, Q3UN58, Q5JPB2, Q5VZ46, Q6GQX2, Q6NZ36, Q6ZSJ8, Q6ZW13, Q76NI1, Q7TNS8, Q80TS7, Q86UU5, Q8IWN7, Q8N6K4, Q8N944
Diamond homologs: A0A2Z4LIS9, A3RK74, A3RK75, A4L7N3, A8MYZ6, B3LYS5, B3P0K6, B4G4S8, B4HF64, B4JSC2, B4KBF6, B4MB78, B4NFR1, B4PTD3, E1BPQ1, G3V7R4, O16850, O43524, P0CG31, P23512, P32182, P32183, P32315, P33205, P33206, P35582, P35583, P35584, P55317, P55318, P84961, P98177, Q07342, Q10924, Q12778, Q28EM1, Q298W7, Q3Y598, Q4VUF1, Q63248
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
615 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:18680737:TCA:T | donor_loss | 1.0000 |
| 17:18680738:CA:C | donor_loss | 1.0000 |
| 17:18680739:A:C | donor_loss | 1.0000 |
| 17:18680825:CAGAA:C | acceptor_gain | 1.0000 |
| 17:18673065:C:CT | acceptor_gain | 0.9900 |
| 17:18680826:AGAA:A | acceptor_gain | 0.9900 |
| 17:18680827:GAA:G | acceptor_gain | 0.9900 |
| 17:18680830:C:CC | acceptor_gain | 0.9900 |
| 17:18682196:CAACT:C | donor_loss | 0.9900 |
| 17:18682197:AACTC:A | donor_loss | 0.9900 |
| 17:18682198:ACTCA:A | donor_loss | 0.9900 |
| 17:18682200:TCA:T | donor_loss | 0.9900 |
| 17:18682201:CACCT:C | donor_loss | 0.9900 |
| 17:18682202:A:AG | donor_loss | 0.9900 |
| 17:18682202:ACCTC:A | donor_gain | 0.9900 |
| 17:18682203:CCTCC:C | donor_gain | 0.9900 |
| 17:18677326:T:TA | donor_gain | 0.9800 |
| 17:18680736:CTCA:C | donor_gain | 0.9800 |
| 17:18680739:A:AC | donor_gain | 0.9800 |
| 17:18680740:C:CC | donor_gain | 0.9800 |
| 17:18680828:AA:A | acceptor_gain | 0.9800 |
| 17:18681616:T:TA | donor_gain | 0.9800 |
| 17:18682202:A:AC | donor_gain | 0.9800 |
| 17:18682202:ACCT:A | donor_gain | 0.9800 |
| 17:18682203:C:CC | donor_gain | 0.9800 |
| 17:18682203:CCT:C | donor_gain | 0.9800 |
| 17:18682203:CCTC:C | donor_gain | 0.9800 |
| 17:18673067:C:CT | acceptor_gain | 0.9700 |
| 17:18673068:G:T | acceptor_gain | 0.9700 |
| 17:18680735:A:AC | donor_gain | 0.9600 |
AlphaMissense
1843 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:18672433:A:G | L250P | 1.000 |
| 17:18672456:C:A | W242C | 1.000 |
| 17:18672456:C:G | W242C | 1.000 |
| 17:18672345:G:C | F279L | 0.999 |
| 17:18672345:G:T | F279L | 0.999 |
| 17:18672346:A:C | F279C | 0.999 |
| 17:18672346:A:G | F279S | 0.999 |
| 17:18672347:A:G | F279L | 0.999 |
| 17:18672367:A:G | M272T | 0.999 |
| 17:18672369:C:A | W271C | 0.999 |
| 17:18672369:C:G | W271C | 0.999 |
| 17:18672421:G:T | A254D | 0.999 |
| 17:18672430:A:C | I251S | 0.999 |
| 17:18672430:A:G | I251T | 0.999 |
| 17:18672430:A:T | I251N | 0.999 |
| 17:18672443:A:G | Y247H | 0.999 |
| 17:18672458:A:G | W242R | 0.999 |
| 17:18672458:A:T | W242R | 0.999 |
| 17:18672828:C:A | W118C | 0.999 |
| 17:18672828:C:G | W118C | 0.999 |
| 17:18672830:A:G | W118R | 0.999 |
| 17:18672830:A:T | W118R | 0.999 |
| 17:18672388:A:T | L265Q | 0.998 |
| 17:18672418:A:T | I255N | 0.998 |
| 17:18672422:C:G | A254P | 0.998 |
| 17:18672442:T:C | Y247C | 0.998 |
| 17:18672454:C:T | G243E | 0.998 |
| 17:18672347:A:C | F279V | 0.997 |
| 17:18672347:A:T | F279I | 0.997 |
| 17:18672367:A:C | M272R | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000253512 (17:18678729 G>A), RS1000436850 (17:18672562 C>T), RS1000853660 (17:18677118 A>G,T), RS1001326773 (17:18676810 C>T), RS1001581449 (17:18672495 G>A,C,T), RS1001654905 (17:18672247 C>A,T), RS1002194599 (17:18677514 G>A), RS1002264293 (17:18683958 G>A), RS1002662638 (17:18670961 G>A,C), RS1002719216 (17:18679699 T>C,G), RS1002722353 (17:18676575 C>T), RS1003238767 (17:18682112 C>T), RS1003724626 (17:18675234 G>A), RS1004001445 (17:18669880 G>A), RS1004150882 (17:18683456 C>T)
Disease associations
OMIM: gene MIM:620471 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Sunitinib | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Smoke | decreases expression | 1 |
| T-2 Toxin | increases expression | 1 |
| Valproic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.